Welcome to ANM Global!

Law is a personal service business and building a firm is very much tied to building personal relationships. We spend a good chunk of time travelling, building and maintaining personal relationships with existing partners, colleagues and developing new relationships with clients.

Office Location

Delhi:

E-5, 2nd Floor, Defence Colony
New Delhi - 110024
Tel : 011-24336744

----------------------------------------

Mumbai:

Office No. 1410, 14th Floor, Maker Chamber V, Nariman Point, Mumbai
Tel : +91 22-22873499

----------------------------------------

Gurgaon:

Level 18, One Horizon Center, Golf Course Road, DLF Phase 5, Sector 43, Gurgaon 122002, India
Tel : +91 124 668 8146 / +91 124 668 8147

----------------------------------------

Mumbai (Entertainment and Media Practice)

Office No. 213, 2nd Floor, A-wing, Crystal Plaza, Andheri Link Road, Andheri (W), Mumbai.
Tel : 022-62360762

----------------------------------------

Mumbai (Corporate and Transactional Practice)

909/A, Capital Building, Bandra Kurla Complex, East Mumbai- 400098

----------------------------------------

Bangalore:

21/2, 1st Main Road,
Opp Indian overseas Bank,
Gandhinagar,
Bengaluru - 560009

----------------------------------------

Kanpur:

77A, Cantt., Kanpur - 208004

Latest Publications


ALTERNATE INVESTMENT FUNDS - BRIEF

1. SEBI introduced the SEBI (Alternate Investment Funds) Regulations, 2012
(AIF Regulations) in May 2012. These regulations replaced the SEBI (Venture
Capital Funds) Regulations, 1996 (hereinafter VCF Regulations) with effect from
May 21, 2012. However, VCFs existing as on that date would continue to be
regulated by VCF Regulations till the fund or scheme managed is wound up. All other and subsequent VCFs would be required to be governed under the AIF Regulations.

MERGER CONTROL-RECENT REGULATIONS

The Competition Commission of India (“CCI”) vide notification dated April 4, 2013 has
amended the Competition Commission of India (Procedure in regard to the transaction
of business relating to combinations) Regulations, 2011, (“CCI Merger Control
Regulations”).
The CCI has amended Schedule I (as per regulation 4 CCI Merger Control Regulations),
which details the categories of transactions ordinarily NOT likely to cause
an appreciable adverse effect on competition in India.

CLINICAL TRIALS IN INDIA

Drug development is a process that calls for utmost care. An error can cause
fatal result. Clinical trials are developed in such a way that it not only helps the
discovery of new drugs but also ensures safety profile of such drugs.

A clinical trial in simple terms can be defined as a set of practice that helps certify a new drug molecule as safe and efficacious before reaching the market.

<< Start < Prev 1 2 3 4 5 6 7 8 Next > End >>

Results 13 - 15 of 23